Creating value in Healthcare and Life Sciences
We work for public and private companies and investors, helping them understand the key commercial questions when growing, buying and selling businesses
Mansfield is a leading healthcare and life sciences strategy consulting firm as ranked by the Financial Times and Vault
We advise on corporate strategy, value creation and commercial due diligence by combining research, modelling and analysis with clinical, scientific and operational knowledge
Selected Clients and Assets we have worked on
Our Latest Insights
Expert analysis across healthcare, life sciences, pharma, social care and digital
News & Insights
Healthcare news, data and analysis
Via Investors in Healthcare
Rubicon Healthcare Partners (RHP), a growth equity asset manager primarily focused on Nordic life science companies, has appointed Claire Knoph as COO and CFO. Her appointment brings dedicated operational and […]
Norway: Rubicon Healthcare Partners appoints Claire Knoph as COO/CFO
3 June 2026
Life Sciences
,
News
,
People
,
Pharma
,
Services – CRO/CMO/CDMO
Star Capital Partnership, a UK-based private equity firm focused on asset-based businesses in Western Europe, has acquired the Glenholme Specialist Care Division (Glenholme SC) from Glenholme Healthcare Group, a UK-based […]
UK: Star Capital Partnership acquires Glenholme’s specialist care division
3 June 2026
Buy Out
,
Care Homes
,
Complex Behavioural Care
,
M&A
,
M&A Deals
Christie & Co has launched a new sentiment survey to capture the perspectives, experiences, and plans of care home operators across the UK. It’s an opportunity to contribute directly to […]
UK: Take part in the Christie & Co UK Care Home Sentiment survey
2 June 2026
Care Homes
,
News
,
Social Care
,
Christie & Co
,
UK
Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction valued of up to US$1.15bn consisting […]
Belgium: UCB completes acquisition of Neurona Therapeutics
2 June 2026
M&A
,
Manufacturing – Specialty Pharma
,
News
,
Pharma
,
Belgium
Cooper Consumer Health, a France-based European consumer healthcare company, has acquired the Ferrer Consumer Healthcare business in Spain. Cooper Consumer Health’s Spanish business grew fivefold in 2024 through the acquisition […]
Spain: Cooper Consumer Health acquires the Ferrer Consumer Healthcare business in Spain
2 June 2026
Consumer Healthcare
,
Healthcare
,
M&A
,
News
,
Avista Capital
France-based Servier, an independent international pharmaceutical group governed by a foundation, is to acquire sevasemten and the muscular dystrophy business of Edgewise Therapeutics, a US-based muscle disease biopharmaceutical company, for up to US$2.65bn, consisting of an […]
France: Servier acquires muscular dystrophy business of Edgewise Therapeutics for up to US$2.65bn
1 June 2026
M&A
,
Manufacturing – Specialty Pharma
,
News
,
Pharma
,
Centerview Partners
US-based Signant Health, an evidence generation company, has acquired Ametris (formerly ActiGraph), a global digital health solutions provider, from Archimed. Signant Health was formed in 2018 by the merger of CRF […]
US: Genstar-backed Signant Health acquires Ametris from Archimed
1 June 2026
Buy Out
,
Life Sciences
,
M&A
,
Medtech – Healthcare IT
,
News
John Gillie has been appointed CFO at Sciensus, a UK-based provider of complex clinical care at home. Gillie brings more than 34 years of experience in pharma services and life […]
UK: John Gillie appointed as CFO at Sciensus
1 June 2026
Distribution
,
Healthcare
,
Homecare
,
News
,
People
Japan-headquartered Meiji Seika Pharma has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based non-profit organisation. Through […]
Japan: Meiji Seika Pharma invests in GHIC’s Global Health Security Fund
1 June 2026
Life Sciences
,
News
,
Pharma
,
Global Health Investment Corporation (GHIC)
,
Global Health Security Fund (GHSF)
US-based global healthcare and life sciences investor, Ampersand Capital Partners, has announced the closing of its latest fund, Ampersand 2026, with US$1.5bn in LP commitments. Ampersand’s oversubscribed 2026 fund – its […]
US: Ampersand closes AMP-26 fund at US$1.5bn hard cap
1 June 2026
Healthcare
,
Life Sciences
,
News
,
Pharma
,
Ampersand Capital Partners
Switzerland-based global CDMO, CordenPharma, has agreed to acquire AmbioPharm, a US-headquartered peptide API CDMO, from Carlyle. The acquisition builds on CordenPharma’s global facility network of 11 sites in Europe and North […]
Switzerland: CordenPharma expands global peptides platform in US and China
1 June 2026
Buy Out
,
M&A
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
SIX-listed CDMO, Siegfried, has issued a CHF200m four-year bond paying a coupon of 1.35%. “This transaction further strengthens Siegfried’s financial position and maintains strategic flexibility for future growth initiatives,” said […]
Switzerland: Siegfried places CHF200m four-year senior bonds
26 May 2026
Debt
,
News
,
Pharma
,
Services – CRO/CMO/CDMO
,
Reto Suter
Fresenius Medical Care (FME), a global provider of products and services for individuals with renal diseases, intends to execute a €1bn share buyback programme to be executed in tranches over […]
Germany: Fresenius to launch new €1bn share buyback programme in next few weeks
26 May 2026
Digital Health/Healthtech
,
Healthcare
,
News
,
Public Equity
,
Fresenius Medical Care
London- and Singapore-listed Jardine Matheson, an Asia Pacific-focused investment company, has agreed the acquisition of I-MED Radiology Network, a global diagnostic imaging and teleradiology business based in Australia, from funds […]
Australia: Jardines to acquire I-MED from Permira for AUD3.4bn
26 May 2026
Buy Out
,
Diagnostics
,
Healthcare
,
Life Sciences
,
M&A
Avanta Salud Integral, a portfolio company of US-based global alternative investment firm HIG Capital, is to acquire Vitaly Group, one of the leading occupational health and safety (OHS) services providers […]
Spain: HIG Capital to acquire Vitaly Group through portfolio company Avanta Salud in pursuit of international expansion
26 May 2026
Buy Out
,
Consumer Healthcare
,
Digital Health/Healthtech
,
Healthcare
,
M&A
Avista Healthcare Partners, a US-based healthcare-focused private equity firm, and Damier Group, the Belgium-based family office of Yvan Vindevogel, have signed a definitive agreement to acquire sanotact Group, a Germany-based […]
Germany: Avista Healthcare Partners and Damier to acquire sanotact Group
25 May 2026
Buy Out
,
Consumer Healthcare
,
Healthcare
,
M&A
,
News
Ennov, a France-based global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies, has received a strategic growth investment in support of its continued […]
France: Bregal Sagemount and Ardian invest in Ennov’s next phase of growth
25 May 2026
Life Sciences
,
Medtech – Healthcare IT
,
News
,
Venture
,
Alexis Saada
A consortium of funds led by CVC and GBL have entered into binding agreements for the launch of a voluntary cash tender offer for all outstanding ordinary shares of Euronext […]
Italy: CVC and GBL to top-up shareholding of Recordati in take-private bid
22 May 2026
M&A
,
Manufacturing – Generics
,
Manufacturing – Specialty Pharma
,
News
,
Pharma
Neobiomics, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, has received an investment led by HealthCap, a specialist provider of life sciences […]
Sweden: HealthCap invests in Neobiomics to support continued growth in neonatal care
22 May 2026
Life Sciences
,
News
,
Venture
,
Emma Höglund
,
HealthCap
Full-Life Technologies, a clinical stage radiotherapeutics company with operations in Belgium, Germany, and China, has raised US$150m led by Vivo Capital. Vivo was joined in the financing package, consisting of […]
Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets
22 May 2026
Life Sciences
,
Medtech – Diagnostics
,
News
,
Venture
,
Belgium
Central London’s private healthcare market is entering a more nuanced phase of its post‑pandemic cycle. Growth has not disappeared, but the easy gains of the Covid rebound have passed, leaving […]
Ted Townsend on London’s Private Healthcare reset
21 May 2026
Analysis
,
Healthcare
,
Hospitals and Clinics
,
News
,
Real Assets
HIG Bayside Capital Europe, the European special situations and capital solutions affiliate of US-based alternative investment firm, HIG Capital, is providing a £90m (US$121m) unitranche term loan Lifeways Group, the […]
UK: HIG Bayside Capital Europe completes refinancing of Lifeways Group
20 May 2026
Complex Behavioural Care
,
Debt
,
Healthcare
,
Mental Health
,
News
German healthcare technology company, Eterno, has secured a significant investment from Germany-based growth investor, Verdane, in support of the expansion of its AI-native platform for outpatient care. The investment underscores […]
Germany: Verdane supports Eterno’s platform expansion with significant investment
20 May 2026
Life Sciences
,
Medtech – Healthcare IT
,
News
,
Venture
,
Dominik Schwarz
London-based European specialist healthcare investor, GHO, and CBC Group, an Asian healthcare-focused asset manager, are merging to create the world’s largest dedicated healthcare investment manager, with over US$21bn in AUM. […]
UK/Singapore: GHO and CBC merging to create world’s largest healthcare investor
20 May 2026
Healthcare
,
Life Sciences
,
M&A
,
News
,
Pharma
Adragos Pharma, a Germany-based global CDMO, has appointed Konstantinos (Kostas) Rengis as its new CEO, succeeding company founder and CEO for the last six years, Dr Andreas Raabe. Raabe will […]
Germany: Adragos Pharma appoints Kostas Rengis as CEO
19 May 2026
News
,
People
,
Pharma
,
Services – CRO/CMO/CDMO
,
Adragos Pharma